Press Releases

Biopharma PEG Supplies PEG Products For Lipid Nanoparticles (LNPs)

Paradigm Clinical Research Announces Expansion of Site Locations

FDA Clears New Laboratory Blood Glucose Reference Analyzer from Nova Biomedical

The U.S. FDA has cleared Nova Primary™ as a blood glucose reference analyzer for manufacturers of blood glucose measuring devices and clinical researchers. Nova Primary fills the need for a new glucose reference analyzer to replace the discontinued YSI STAT PLUS 2300 Glucose and L-Lactate analyzer (YSI, Inc., Yellow Springs, OH).

Exothera announces a strategic partnership with Quantoom Biosciences and launches a new business unit for the development and production of RNA

Exothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA.

New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

On May 4, 2023, Lonza Bioscience Informatics will present a free 45-minute webinar that includes a discussion with Dr Phanesh Koneru, CEO, Exela® Pharma Sciences.

Onyx Scientific increases non-GMP capabilities with CMC facility expansion

BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets

AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs

AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences.

Elligo Health Research Opens New, Larger Clinical Research Center in Austin

Elligo Health Research®, the largest healthcare-enabling research organization, has opened its new clinical research center in Austin, Texas.

CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor

CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor Registration for must-attend Risk-Based Quality Management event is now open

Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics

Headlands Research Acquires Clinvest Research — the Clinical Research Site Network’s Third Addition of 2023

Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of Clinvest Research, an established site based in Springfield, Missouri. Founded in 1996, Clinvest Research has conducted over 600 trials for chronic diseases and conditions such as headache and migraine, arthritis and chronic pain, and diabetes, as well as weight loss. “The acquisition of Clinvest Research strengthens our chronic pain and endocrinology expertise and increases participant access to clinical trials for highly prevalent diseases and conditions that often remain undiagnosed and untreated,” said Cathy Collins, CEO of Headlands Research.

Improving Clinical Data Management: Challenges, Solutions, and Future Trends

Unlock the power of clinical data management for accurate research and better Clinical research outcomes. Discover the key components, technology advancements, and benefits in this essential field.

BOC Sciences Reports Strong Capabilities of CDMO Operations

BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.

ISCT Reaffirms Position on Addressing Ethical Implications of US Expanded Access Pathway

International Society for Cell & Gene Therapy Publishes Report Exploring Areas for Potential Misuse and Outlines Plans for Future Guidelines to Keep Patients Safe

BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

Enhancing Clinical Trials: The Benefits of Electronic Data Capture (EDC)

Discover how Electronic Data Capture (EDC) revolutionizes clinical trials by streamlining data collection, improving accuracy, and ensuring compliance. Explore the advantages of EDC and its impact on efficient clinical research.

Saudia Cargo agreement with Tower Cold Chain extends choice in Middle East pharmaceutical shipments

Saudia Cargo has added Tower Cold Chain to its approved roster of temperature-controlled containers for shipping pharmaceutical, biotech and life science products, in a new global rental agreement.

Upperton increases oral dosage form capabilities at its Nottingham HQ